174 related articles for article (PubMed ID: 8781597)
1. Effect of calcitonin gene-related peptide on delayed cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits.
Imaizumi S; Shimizu H; Ahmad I; Kaminuma T; Tajima M; Yoshimoto T
Surg Neurol; 1996 Sep; 46(3):263-70; discussion 270-1. PubMed ID: 8781597
[TBL] [Abstract][Full Text] [Related]
2. [Effect of calcitonin gene-related peptide and vasoactive intestinal polypeptide on delayed cerebral vasospasm studied after experimental subarachnoid hemorrhage in rabbits].
Shimizu H; Imaizumi S; Ishtiaq A; Kaminuma T; Tajima M; Yoshimoto T
No Shinkei Geka; 1994 Feb; 22(2):131-9. PubMed ID: 8115007
[TBL] [Abstract][Full Text] [Related]
3. Effects of subarachnoid hemorrhage on vascular responses to calcitonin gene-related peptide and its related second messengers.
Sutter B; Suzuki S; Arthur AS; Kassell NF; Lee KS
J Neurosurg; 1995 Sep; 83(3):516-21. PubMed ID: 7666231
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage.
Toyoda K; Faraci FM; Watanabe Y; Ueda T; Andresen JJ; Chu Y; Otake S; Heistad DD
Circ Res; 2000 Oct; 87(9):818-24. PubMed ID: 11055987
[TBL] [Abstract][Full Text] [Related]
5. Effect of intracisternal and intravenous calcitonin gene-related peptide on experimental cerebral vasospasm in rabbits.
Toshima M; Kassell NF; Tanaka Y; Dougherty DA
Acta Neurochir (Wien); 1992; 119(1-4):134-8. PubMed ID: 1481740
[TBL] [Abstract][Full Text] [Related]
6. Prevention of cerebral vasospasm by calcitonin gene-related peptide slow-release tablet after subarachnoid hemorrhage in monkeys.
Inoue T; Shimizu H; Kaminuma T; Tajima M; Watabe K; Yoshimoto T
Neurosurgery; 1996 Nov; 39(5):984-90. PubMed ID: 8905755
[TBL] [Abstract][Full Text] [Related]
7. Relaxant effect of calcitonin gene-related peptide on cerebral arterial spasm induced by experimental subarachnoid hemorrhage in dogs.
Nozaki K; Uemura Y; Okamoto S; Kikuchi H; Mizuno N
J Neurosurg; 1989 Oct; 71(4):558-64. PubMed ID: 2795174
[TBL] [Abstract][Full Text] [Related]
8. Vascular pathology of large cerebral arteries in experimental subarachnoid hemorrhage: Vasoconstriction, functional CGRP depletion and maintained CGRP sensitivity.
Johansson SE; Abdolalizadeh B; Sheykhzade M; Edvinsson L; Sams A
Eur J Pharmacol; 2019 Mar; 846():109-118. PubMed ID: 30653947
[TBL] [Abstract][Full Text] [Related]
9. The importance of substance P and calcitonin gene related peptide as vasodilator neuropeptide during acute phase of experimental posthemorrhagic vasospasm.
Locatelli M
J Neurosurg Sci; 2000 Dec; 44(4):186-91. PubMed ID: 11327287
[TBL] [Abstract][Full Text] [Related]
10. Development of calcitonin gene-related peptide slow-release tablet implanted in CSF space for prevention of cerebral vasospasm after experimental subarachnoid haemorrhage.
Ahmad I; Imaizumi S; Shimizu H; Kaminuma T; Ochiai N; Tajima M; Yoshimoto T
Acta Neurochir (Wien); 1996; 138(10):1230-40. PubMed ID: 8955444
[TBL] [Abstract][Full Text] [Related]
11. Depletion of calcitonin gene-related peptide in perivascular nerves during acute phase of posthemorrhagic vasospasm in the rabbit.
Arienta C; Balbi S; Caroli M; Fumagalli G
Brain Res Bull; 1991 Nov; 27(5):605-9. PubMed ID: 1756379
[TBL] [Abstract][Full Text] [Related]
12. Involvement of perivascular sensory fibers in the pathophysiology of cerebral vasospasm following subarachnoid hemorrhage.
Edvinsson L; Delgado-Zygmunt T; Ekman R; Jansen I; Svendgaard NA; Uddman R
J Cereb Blood Flow Metab; 1990 Sep; 10(5):602-7. PubMed ID: 1696581
[TBL] [Abstract][Full Text] [Related]
13. Cerebrovascular changes following administration of gammaglobulins against substance P or calcitonin gene related peptide in monkey with subarachnoid haemorrhage.
Shiokawa Y; Holst JJ; Torben J; Rasmussen N; Schmidt P; Svendgaard NA
Br J Neurosurg; 1993; 7(5):507-18. PubMed ID: 7505591
[TBL] [Abstract][Full Text] [Related]
14. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor.
Wolf EW; Banerjee A; Soble-Smith J; Dohan FC; White RP; Robertson JT
J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124
[TBL] [Abstract][Full Text] [Related]
15. [Reversal of experimental cerebral vasospasm by neuropeptides].
Nozaki K
Nihon Geka Hokan; 1990 Jan; 59(1):55-67. PubMed ID: 2130769
[TBL] [Abstract][Full Text] [Related]
16. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB.
Zhang Z; Nagata I; Kikuchi H; Xue JH; Sakai N; Sakai H; Yanamoto H
Stroke; 2001 Jul; 32(7):1665-72. PubMed ID: 11441217
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.
Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA
Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855
[TBL] [Abstract][Full Text] [Related]
18. Dipyrone attenuates cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits.
Silav G; Ergün H; Dolgun H; Sancak T; Sargon MF; Egemen N
J Neurosurg Sci; 2017 Aug; 61(4):380-387. PubMed ID: 25366581
[TBL] [Abstract][Full Text] [Related]
19. Changes in vascular responses of the basilar artery to acetylcholine and endothelin-1 in an experimental rabbit vasospasm model.
Kim CY; Paek SH; Seo BG; Kim JH; Han DH
Acta Neurochir (Wien); 2003 Jul; 145(7):571-7. PubMed ID: 12910400
[TBL] [Abstract][Full Text] [Related]
20. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage.
Atalay B; Caner H; Cekinmez M; Ozen O; Celasun B; Altinors N
Neurosurgery; 2006 Nov; 59(5):1102-7; discussion 1107-8. PubMed ID: 17143244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
